Summary: Scientists have long observed that individuals carrying the APOE2 variant of the apolipoprotein E gene tend to live longer and have a lower risk of Alzheimer’s disease, but the biological reason remained a mystery.
A new study reveals that APOE2 acts as a genomic protector. The research shows that APOE2 helps human neurons maintain DNA integrity and resist entering senescence, a dysfunctional, “zombie-like” state that drives neurodegeneration.
Key Research Findings
- DNA Integrity: APOE2 neurons accumulate significantly less DNA damage than other variants. RNA sequencing revealed that these neurons strongly upregulate DNA repair and damage-response pathways.
- Resisting Cellular Aging: When stressed with radiation or chemotherapy, APOE2 neurons showed lower levels of senescence markers (such as p16) and better-preserved nuclear architecture compared to APOE3 and APOE4.
- Transferable Protection: In a promising laboratory finding, adding recombinant APOE2 protein to high-risk APOE4 neurons reduced their DNA damage signaling, suggesting the protective effect might be transferable via therapy.
- Cross-Species Validation: Aged mice with the human APOE2 gene showed healthier brain features, including better-preserved heterochromatin and higher levels of nuclear scaffolding proteins in the hippocampus.
- Faster Recovery: Beyond having less damage at baseline, APOE2 neurons were found to recover more quickly when subjected to cellular stress.
Source: Buck Institute
People who carry the APOE2 version of the apolipoprotein E gene are more likely to live to advanced age and are partly protected against Alzheimer’s disease, but scientists have struggled to explain why.
A new study from the Buck Institute for Research on Aging, now published in Aging Cell, offers a mechanistic answer: APOE2 helps human neurons keep their DNA intact and resist becoming senescent, a damaged, dysfunctional state that accumulates with age and contributes to neurodegeneration.
The findings shift attention away from APOE’s well-known role in cholesterol transport and toward a previously underappreciated function of the gene: shaping how brain cells maintain the integrity of their genome as they age.
“We’ve known for years that APOE2 carriers tend to live longer and have a lower risk of Alzheimer’s, but the protective mechanism has been a black box,” says senior author Lisa M. Ellerby, PhD, professor at the Buck Institute.
“Our work shows that APOE2 neurons are better at preventing and repairing DNA damage, and they resist the cellular aging program that drives so much of late-life decline. Our findings point to entirely new therapeutic directions.”
What the researchers did
APOE comes in three common forms, APOE2, APOE3, and APOE4, that differ by just two amino acids. APOE4 is the strongest known genetic risk factor for late-onset Alzheimer’s disease (typically after age 65), while APOE2 is consistently linked in population studies to exceptional longevity and reduced dementia risk.
To isolate what APOE itself contributes to neuronal aging, the Buck team used human induced pluripotent stem cells (iPSCs) genetically engineered to differ only at the APOE locus.
They generated two types of brain neurons from these cells, inhibitory GABAergic neurons and excitatory glutamatergic neurons, and compared how the different APOE versions affected each cell type. They also examined hippocampal tissue from aged mice carrying the human APOE2, APOE3, or APOE4 gene.
Key findings
APOE2 neurons accumulate less DNA damage. Bulk and single-cell RNA sequencing showed that APOE2 GABAergic neurons strongly upregulate DNA repair and damage-response pathways, while APOE4 neurons show transcriptional signatures associated with Alzheimer’s disease. Direct measurements of DNA strand breaks confirmed that APOE2 neurons carried significantly less damage.
APOE2 neurons resist becoming senescent. When the team stressed excitatory neurons with radiation or the chemotherapy drug doxorubicin, APOE2 neurons showed lower levels of senescence markers (including p16 and CRYAB), smaller nucleoli, and better-preserved nuclear architecture compared with APOE3 and APOE4 neurons.
APOE2 protein can protect APOE4 neurons. Adding recombinant APOE2 protein to APOE4 neurons reduced DNA damage signaling after radiation, an early hint that the protective effect might be transferable, not just genetic.
The mouse brain agrees. Aged APOE2 knock-in mice showed smaller nucleoli, higher levels of the nuclear scaffolding protein Lamin A/C, and better-preserved heterochromatin in the hippocampus than APOE3 or APOE4 mice, features associated with healthier brain aging.
Why it matters
Cellular senescence and accumulated DNA damage are now recognized as central drivers of aging and age-related disease, including Alzheimer’s. “Until now, the APOE field has focused largely on lipid handling and amyloid-beta biology,” says Ellerby. “By showing that APOE alleles also tune how neurons defend their genome, this study connects a major longevity gene to two of the most actively studied hallmarks of aging.”
Ellerby says the work suggests that strategies aimed at boosting DNA repair or clearing senescent cells in the brain could mimic some of the natural protection conferred by APOE2, potentially benefiting people who carry the higher-risk APOE4 variant.
“What surprised us was how consistent the picture was across two very different neuron types and across human cells and mouse brain tissue,” said co-first author Cristian Gerónimo-Olvera, PhD, a postdoctoral fellow at the Buck Institute. “APOE2 neurons aren’t just less damaged at baseline, they recover faster when stressed.”
Next steps
The authors note that the precise molecular mechanism by which APOE2 stabilizes the nuclear envelope and supports DNA repair remains to be defined. Future studies will explore whether APOE2-mimetic compounds or targeted DNA repair therapies can confer similar protection in APOE4 carriers, the population at highest genetic risk for Alzheimer’s disease.
Funding: This work was supported by the National Institute on Aging (R01AG061879, P01AG066591, T32 AG000266), the Paul F. Glenn Center for Biology of Aging, the Hevolution Foundation (HF-PART-23-1422047), and a CatalystX award from Alex and Bob Griswold and the Valley Foundation Fellowship.
Key Questions Answered:
A: Population studies consistently link APOE2 to advanced age and reduced Alzheimer’s risk. While the field previously focused on its role in cholesterol, this study shows it is a master regulator of genomic stability, keeping brain cells “young” by preventing DNA breaks.
A: Senescence is a damaged, dysfunctional state where cells stop dividing but don’t die, often accumulating with age. These “zombie” cells contribute to neurodegeneration by promoting inflammation and decline. APOE2 effectively shields neurons from falling into this state.
A: Not necessarily. This research points toward new therapeutic directions, such as APOE2-mimetic compounds or targeted DNA repair therapies. Scientists hope to develop treatments that mimic the natural protection of APOE2 to benefit high-risk APOE4 carriers.
Editorial Notes:
- This article was edited by a Neuroscience News editor.
- Journal paper reviewed in full.
- Additional context added by our staff.
About this neuroscience and genetics research news
Author: Kris Rebillot
Source: Buck Institute
Contact: Kris Rebillot – Buck Institute
Image: The image is credited to Neuroscience News
Original Research: Open access.
“Exceptional Longevity Modifying Allele APOE2 Promotes DNA Signaling Pathways Resisting Cellular Senescence in Human Neurons” by Cristian Gerónimo-Olvera, Stephen M. Scheeler, Carlos Galicia Aguirre, Genesis Vega-Hormazabal, Daniela Garcia, Long Wu, Natalia Murad, Kevin Schneider, Kenneth A. Wilson, Nikola T. Markov, Sicheng Song, Jesse Simons, Akos A. Gerencser, Emily Parlan, Sean D. Mooney, Eric Verdin, Judith Campisi, Tara E. Tracy, David Furman, Simon Melov, Lisa M. Ellerby. Aging Cell
DOI:10.1111/acel.70494
Abstract
Exceptional Longevity Modifying Allele APOE2 Promotes DNA Signaling Pathways Resisting Cellular Senescence in Human Neurons
Genome-wide association studies (GWAS) have identified APOE2 allele as linked to exceptional longevity, with carriers exhibiting a reduced risk of Alzheimer’s disease (AD). Apolipoprotein E (APOE), a glycoprotein involved in lipid transport, has three major alleles.
However, alterations in lipid metabolism alone do not fully explain APOE2’s protective effects. In contrast, APOE4 is the strongest genetic risk factor for AD.
To investigate how APOE2 promotes neuronal longevity and confers neuroprotection, we generated human isogenic APOE iPSC-derived models of both inhibitory GABAergic and excitatory neurons.
In GABAergic neurons, APOE alleles differentially influenced endogenous DNA damage, DNA repair, and neuronal motility. Single-cell RNA sequencing revealed APOE4-specific gene expression signatures associated with AD, whereas APOE2 GABAergic neurons were enriched for DNA repair and signaling pathways.
Consistent with this, APOE2 neurons exhibited significantly lower levels of DNA damage. APOE4 GABAergic neurons exhibit increased expression of repetitive ribosomal RNA, which is associated with DNA damage and cellular senescence.
To determine whether the effects extended to excitatory neurons, we used a separate human model of Ngn2-induced glutamatergic neurons, and found that APOE2 excitatory neurons were more resistant to cellular senescence and DNA damage than isogenic APOE3 and APOE4 neurons.
Similarly, we found human APOE2-targeted replacement mice exhibited less nucleolar enlargement and increased nuclear Lamin A/C, Hmgb1, and H3K9me3 compared to APOE4 counterparts.
Together, our findings identify DNA repair and suppression of senescence-associated processes as key mechanisms by which APOE2 is associated with neuronal resilience, providing mechanistic insight into its association with exceptional longevity and protection against AD.
